Correction: Cancer Cell Int (2020) 20:372 https://doi.org/10.1186/s12935-020-01471-w


In this article [1], there was an error in Fig. 6. The corrected Fig. 6 is given below.

Fig. 6
figure 6

The efect of ACTA2-AS1/miR-143-3p/SMAD3 axis on progression of CC. a The knock-down ability of si-SMAD3 in HeLa and SiHa cells was confrmed by qRT-PCR. b The over-expression ability of pcDNA-ACTA2-AS1 was confrmed by qRT-PCR. c Cell viability was detected by CCK8 assay after transfecting with si-SMAD3 and co-transfecting with pcDNA‐ACTA2‐AS1 or miR-143-3p inhibitor. d The migration ability of transfected cells was analyzed by transwell assay. e Apoptosis condition of transfected cells was analyzed by fow cytometry analysis. ** P<0.05